HK Stock Market Move | CHENMING PAPER(01812) surges over 6% as all five major production bases have resumed production fully, resulting in overall production capacity being restored to 100%.
Chenming Paper (01812) rose more than 6%, as of the time of publication, it is up 6.61% to 1.29 Hong Kong dollars, with a turnover of 2.036 million Hong Kong dollars.
CHENMING PAPER (01812) rose more than 6%, as of the time of writing, it rose by 6.61% to 1.29 Hong Kong dollars, with a turnover of 2.036 million Hong Kong dollars.
In terms of news, CHENMING PAPER announced that with the strong support of the party committees, government at all levels, and financial institutions, the company has strengthened enterprise management comprehensively, adjusted product structure according to market conditions, and orderly promoted the resumption of work and production at various production bases. As of the announcement date, the five major production bases in Shouguang, Zhanjiang, Huanggang, Jiangxi, and Jilin have fully resumed production, and the overall production capacity of the company has been restored to 100%.
CHENMING PAPER stated that the five major production bases of the company have fully resumed production, which can effectively improve the company's operating cash flow and gradually restore its own blood generation function. In the next step, the company will strengthen the whole process of cost reduction and efficiency improvement, as well as comprehensive new product development, continuously enhance the company's profitability and market competitiveness, effectively resolve the company's debt risk, and promote the company's sustainable, stable, and healthy development.
Related Articles

HK Stock Market Move | JD HEALTH (06618) rose more than 4% and deepened its strategic cooperation with Jiangsu Yuyue Medical Equipment & Supply in AI medical devices, with a focus on blood glucose management and respiratory health.

HK Stock Market Move | AKESO (09926) up another 4%, the company's first triple-criticism AK150 recently received clinical approval.

Orient: The brain-computer interface market has vast potential for development. It is recommended to focus on the two major directions of semi-invasive technology and its industrial chain.
HK Stock Market Move | JD HEALTH (06618) rose more than 4% and deepened its strategic cooperation with Jiangsu Yuyue Medical Equipment & Supply in AI medical devices, with a focus on blood glucose management and respiratory health.

HK Stock Market Move | AKESO (09926) up another 4%, the company's first triple-criticism AK150 recently received clinical approval.

Orient: The brain-computer interface market has vast potential for development. It is recommended to focus on the two major directions of semi-invasive technology and its industrial chain.






